Vicarious Surgical (RBOT): CTO Khalifa Sammy Granted 25,025 Options
Khalifa Sammy, identified as a director, a 10% owner and Chief Technology Officer of Vicarious Surgical Inc. (RBOT), reported an equity award on 06/27/2025.
Rhea-AI Filing Summary
Khalifa Sammy, identified as a director, a 10% owner and Chief Technology Officer of Vicarious Surgical Inc. (RBOT), reported an equity award on 06/27/2025. The filing shows acquisition of 25,025 stock options with an exercise price of $7.61. The options vest in 48 equal monthly installments beginning on the one-month anniversary of the grant, tying vesting to continued service. The options appear to carry a term that ends on 06/26/2035, and the number of derivative securities beneficially owned following the transaction is 25,025. The form is signed by an attorney-in-fact on 08/11/2025.
Positive
- Khalifa Sammy, a director and CTO, acquired 25,025 stock options, demonstrating management alignment with shareholder value
- Options vest in 48 equal monthly installments, which supports long-term retention and performance incentives
- Exercise price is $7.61 with an apparent expiration date of 06/26/2035, providing a standard long-term exercise window
Negative
- None.
Insights
TL;DR: Insider option grant aligns senior management with long-term performance but size relative to share base is not disclosed.
The reported grant to Khalifa Sammy creates a multi-year incentive through 25,025 options at a $7.61 strike vesting monthly over four years. Such schedules encourage retention and link compensation to long-term share performance. Without information on outstanding shares or immediate vesting, the market impact and dilution cannot be quantified from this filing alone. The 10-year apparent term to 06/26/2035 is standard for equity grants and provides a long runway for potential exercise.
TL;DR: Grant to a director/CTO is a routine governance action but requires disclosure context to assess materiality.
As both a director and an officer, Khalifa Sammy receiving an award is consistent with compensation practices for senior executives. The 48-month monthly vesting indicates a retention-focused design. The Form 4 properly discloses relationship, transaction date (06/27/2025), and post-transaction ownership (25,025 options). Materiality for shareholders depends on total share count and prior holdings, which are not provided here.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 25,025 | $0.00 | $0.00 |
Footnotes (1)
- F1. The shares underlying this option vest in 48 equal monthly installments beginning on the one-month anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction was reported for Vicarious Surgical (RBOT)?
Who is the reporting person on the RBOT Form 4?
What are the key terms of the options granted to the RBOT insider?
How many derivative securities does the reporting person own after the transaction?
When was the Form 4 signed?
AI-generated analysis. How Rhea-AI works. Not financial advice.